Ion transport pathology in the mechanism of sickle cell dehydration

Physiological Reviews

Volumn 85, Issue 1, 2005, Pages 179-200

  Lew, Virgilio L ^a   Bookchin, Robert M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM ION; CHLORIDE ION; DEOXYHEMOGLOBIN; HEMOGLOBIN F; IONOPHORE; POTASSIUM ION; SODIUM ION;

ANION TRANSPORT; CELL AGING; CHLORIDE TRANSPORT; DEHYDRATION; ENDOCYTOSIS; ENDOSOME; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HOMEOSTASIS; HUMAN; ION TRANSPORT; MATHEMATICAL MODEL; PATHOPHYSIOLOGY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; SODIUM TRANSPORT;

ANEMIA, SICKLE CELL; ANIONS; DEHYDRATION; HUMANS; ION CHANNELS; POTASSIUM; SODIUM;

EID: 12844273669     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00052.2003     Document Type: Review

References (277)

1. Akide-Ndunge OB, Ayi K, and Arese P. The Haldane malaria hypothesis: facts, artifacts, and a prophecy. Redox Rep 8: 311-316, 2003.
2. Allison AC. Notes on sickle-cell polymorphism. Ann Hum Genet 19: 39-51, 1954.
3. Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 4857: 290-294, 1954.
4. + channels in the human red cell. Biochim Biophys Acta 903: 543-546, 1987.
5. + channels by cytochrome P-450 inhibitors. J Biol Chem 267: 11789-11793, 1992.
6. Anderson K, Crable SC, Gallagher PG, and Joiner CH. Expression of multiple KCl cotransporter isoforms in sickle and normal erythroid cells. Blood 100: 666a, 2002.
7. Arese P, Turrini F, Bussolino F, Lutz HU, Chiu D, Zuo L, Kuypers F, and Ginsburg H. Recognition signals for phagocytic removal of favic, malaria-infected and sickled erythrocytes. Adv Exp Med Biol 307: 317-327, 1991.
8. Atweh GF, DeSimone J, Saunthararajah Y, Fathallah H, Weinberg RS, Nagel RL, Fabry ME, and Adams RJ. Hemoglobinopathies. Hematology 2003: 14-39, 2003.
9. Ayi K, Turrini F, Piga A, and Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes. A common mechanism that may explain protection against falciparum-malaria in sickle-trait and beta-thalassemia- trait. Blood. In press.
10. Beaugé L and Lew VL. Passive fluxes of sodium and potassium across red cell membranes. In: Membrane Transport in Red Cells, edited by J. C. Ellory and V. L. Lew. London: Academic, 1977, p. 39-51.
11. Bennekou P. The feasibility of pharmacological volume control of sickle cells is dependent on the quantization of the transport pathways. A model study. J Theoret Biol 196: 129-137, 1999.
12. Bennekou P, De Franceschi L, Pedersen O, Lian L, Asakura T, Evans G, Brugnara C, and Christophersen P. Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease. Blood 97: 1451-1457, 2001.
13. Bennekou P, Pedersen O, Moller A, and Christophersen P. Volume control in sickle cells is facilitated by the novel anion conductance inhibitor NS1652. Blood 95: 1842-1848, 2000.
14. Bennekou P and Stampe P. The effect of ATP, intracellular calcium and the anion exchange inhibitor DIDS on conductive anion fluxes across the human red cell membrane. Biochim Biophys Acta 942: 179-185, 1988.
15. Benzaquen LR, Brugnara C, Byers HR, Gatton-Celli S, and Halperin JA. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med 1: 534-540, 1995.
16. Berkowitz LR and Orringer EP. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability. J Clin Invest 68: 1215-1220, 1981.
17. Bertles JF and Milner PFA. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle cell anemia. J Clin Invest 47: 1731-1741, 1968.
18. Billett HH, Fabry ME, and Nagel RL. Hemoglobin distribution width: a rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia. J Lab Clin Med 112: 339-344, 1988.
19. Billett HH, Kim K, Fabry ME, and Nagel RL. The percentage of dense red cells does not predict incidence of sickle cell painful crisis. Blood 68: 301-303, 1986.
20. Billett HH, Nagel RL, and Fabry ME. Evolution of laboratory parameters during sickle cell painful crisis: evidence compatible with dense red cell sequestration without thrombosis. Am J Med Sci 296: 293-298, 1988.
21. Bize I. Theoretical validation for a model of KCC regulation in human erythrocytes. Blood Cells Mol Dis 27: 121-126, 2001.
22. Bize I and Dunham PB. Staurosporine, a protein kinase inhibitor, activates K-Cl cotransport, in LK sheep erythrocytes. Am J Physiol Cell Physiol 266: C759-C770, 1994.
23. Bize I, Guvenc B, Robb A, Buchbinder G, and Brugnara C. Serine/threonine protein phosphatases and regulation of K-Cl cotransport, in human erythrocytes. Am J Physiol Cell Physiol 277: C926-C936, 1999.
24. Bize I, Guvenc B, Robb A, Buchbinder G, and Brugnara C. Serine/threonine protein phosphatases and regulation of K-Cl cotransport in human erythrocytes. Am J Physiol Cell Physiol 277: C926-C936, 1999.
25. Bize I, Munoz P, Canessa M, and Dunham PB. Stimulation of membrane serine-threonine phosphatase in erythrocytes by hydrogen peroxide and staurosporine. Am J Physiol Cell Physiol 274: C440-C446, 1998.
26. Bize I, Taher S, and Brugnara C. Regulation of K-Cl cotransport during reticulocyte maturation and erythrocyte aging in normal and sickle erythrocytes. Am J Physiol Cell Physiol 285: C31-C38, 2003.
27. Bookchin RM, Balazs T, and Lew VL. Measurement of the hemoglobin concentration in deoxyhemoglobin S polymers and characterization of the polymer water compartment. J Mol Biol 244: 100-109, 1994.
28. +, "valinomycin-resistant" red cells in Hb E/beta-thalassemia, beta-thalassemia intermedia, and sickle cell anemia: a possible result of oxidative membrane damage? Proc Symp Oxidative Stress in Thalassemia: Etiology and Prevention Petchburi Thailand 2002.
29. +, low-density sickle and normal red cells. Proc Natl Acad Sci USA 97: 8045-8050, 2000.
30. Bookchin RM and Lew VL. Progressive inhibition of the Ca pump and Ca:Ca exchange in sickle red cells. Nature 284: 561-563, 1980.
31. Bookchin RM and Lew VL. Effect of a "sickling pulse" on calcium and potassium transport in sickle cell trait red cells. J Physiol 312: 265-280, 1981.
32. Bookchin RM and Lew VL. Calcium transport abnormalities in sickle-cell anemia red cells: Ca-pump failure or concealed IOVS? Acta Physiol Latinoam 32: 224-226, 1982.
33. Bookchin RM and Lew VL. Red cell membrane abnormalities in sickle cell anemia. Prog Hematol 13: 1-23, 1983.
34. Bookchin RM, Ortiz OE, Hockaday A, Sepulveda MI, and Lew VL. The state of calcium in sickle cell anemia red cells. In: Intracellular Calcium Regulation, edited by H. Bader, K. Gietzen, J. Rosenthal, R. Rudel, and H. U. Wolf. Wolfeboro, NH: Manchester Univ. Press, 1986, p. 327-334.
35. Bookchin RM, Ortiz OE, and Lew VL. Silent intracellular calcium in sickle cell anemia red cells. In: The Red Cell. Proceedings of the Sixth International Conference on Red Cell Metabolism and Function, edited by G. J. Brewer. New York: Liss, 1984, p. 17-28.
36. Bookchin RM, Ortiz OE, and Lew VL. Mechanisms of red cell dehydration in sickle cell anemia. Application of an integrated red cell model. In: The Red Cell Membrane: A Model for Solute Transport, edited by B. U. Raess and G. Tunnicliffe. Clifton, NJ: Humana, 1990, p. 443-461.
37. Bookchin RM, Ortiz OE, and Lew VL. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest 87: 113-124, 1991.
38. Bookchin RM, Ortiz OE, Somlyo AV, Somlyo AP, Sepulveda MI, Hockaday A, and Lew VL. Calcium-accumulating inside-out vesicles in sickle cell anemia red cells. Trans Assoc Am Phys 98: 10-20, 1985.
39. Bookchin RM, Tiffert JT, Davies SC, Vichinsky E, and Lew VL. Magnesium Therapy for Sickle Cell Anemia: A New Rationale, edited by Y. Beuzard, B. Lubin, and J. Rosa. Paris: Libbey Eurotext, 1995, p. 545-546.
40. Boyer SH, Belding TK, Margolet L, and Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science 188: 361-363, 1975.
41. Branton D, Cohen CM, and Tyler J. Interaction of cytoskeletal proteins on the human erythrocyte membrane. Cell 24: 24-32, 1981.
42. Bridges KR, Barabino GD, Brugnara C, Cho MR, Christoph GW, Dover G, Ewenstein BM, Golan DE, Guttmann CR, Hofrichter J, Mulkern RV, Zhang B, and Eaton WA. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 88: 4701-4710, 1996.
43. Brown AM, Ellory JC, Young JD, and Lew VL. A calcium-activated potassium channel present: in foetal red cells of the sheep but absent from reticulocytes and mature red cells. Biochim Biophys Acta 511: 163-175, 1978.
44. Brown AM and Simonsen LO. Intracellular cobalt buffering by intact human red cells: evidence for time-dependent, and metabolism-dependent changes (Abstract). J Physiol 361: 26P, 1985.
45. + channel: the imidazole ring is not required for inhibitory activity. J Pharmacol Exp Ther 273: 266-272, 1995.
46. Brugnara C, Bunn HF, and Tosteson DC. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 232: 388-390, 1986.
47. Brugnara C, Bunn HF, and Tosteson DC. Ion content and transport and the regulation of volume in sickle cells. Ann NY Acad Sci 565: 96-103, 1989.
48. + transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins. J Biol Chem 268: 8760-8768, 1993.
49. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 92: 520-526, 1993.
50. Brugnara C, De Franceschi L, Bennekou P, Alper SL, and Christophersen P. Novel therapies for prevention of erythrocyte dehydration in sickle cell anemia. Drug News Perspect 14: 208-220, 2001.
51. Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL, and Platt OS. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin invest 97: 1227-1234, 1996.
52. Brugnara C, Kopin AS, Bunn HF, and Tosteson DC. Regulation of cation content and cell volume in erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 75: 1608-1617, 1985.
53. Brugnara C and Tosteson DC. Inhibition of K transport, by divalent cations in sickle erythrocytes. Blood 70: 1810-1815, 1987.
54. Bunn HF and Forget BG. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, PA: Saunders, 1986.
55. Cabantchik ZI, Knauf PA, and Rothstein A. The anion transport system of the red blood cell. The role of membrane protein evaluated by the use of "probes." Biochim Biophys Acta 515: 239-302, 1978.
56. Cabantchik ZI and Rothstein A. The nature of the membrane sites controlling anion permeability of human red blood cells as determined by studies with disulfonic stilbene derivatives. J Membr Biol 10: 311-330, 1972.
57. + efflux is highly expressed in young human red cells containing normal hemoglobin or HbS. J Membr Biol 97: 97-105, 1987.
58. 2+ modulation. Blood 70: 1861-1866, 1987.
59. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D, Simula G, Luzzatto L, and Arese P. Early phagocytosis of glucose-6-phosphate dehydrogenase (GGPD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 92: 2527-2534, 1998.
60. Carafoli E. Calcium pump of the plasma membrane. Physiol Rev 71: 129-153, 1991.
61. Carafoli E. Plasma membrane calcium pump: structure, function and relationships. Basic Res Cardiol 92 Suppl 1: 59-61, 1997.
62. Carafoli E and Molinari M. Calpain: a protease in search of a function? Biochem Biophys Res Commun 247: 193-203, 1998.
63. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, and Orringer EP. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine 75: 300-326, 1996.
64. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, and Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332: 1317-1322, 1995.
65. Charache S, Terrin ML, Moore RD, Dover GJ, McMahon RP, Barton FB, Waclawiw M, and Eckert SV. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials 16: 432-446, 1995.
66. Chasis JA and Mohandas N. Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations. J Cell Biol 103: 343-350, 1986.
67. Chasis JA, Prenant M, Leung A, and Mohandas N. Membrane assembly and remodeling during reticulocyte maturation. Blood 74: 1112-1120, 1989.
68. Clark MR. Senescence of red blood cells: progress and problems. Physiol Rev 68: 503-554, 1988.
69. Clark MR, Guatelli JC, Mohandas N, and Shohet SB. Influence of red cell water content on the morphology of sickling. Blood 55: 823-830, 1980.
70. + and water contents. Biochim Biophys Acta 646: 422-432, 1981.
71. Clark MR, Mohandas N, Feo C, and Jacobs MS. Separate mechanisms of deformability loss in ATP-depleted and Ca-loaded erythrocytes. J Clin Invest 67: 531-539, 1981.
72. Clark MR, Mohandas N, and Shohet SB. Deformability of oxygenated irreversibly sickled cells. J Clin Invest 65: 189-196, 1980.
73. Clark MR, Morrison CE, and Shohet SB. Monovalent cation transport in irreversibly sickled cells. J Clin Invest 62: 329-337, 1978.
74. Clark MR and Rossi ME. Permeability characteristics of deoxygenated sickle cells. Blood 76: 2139-2145, 1990.
75. Clark MR, Ungar RC, and Shohet SB. Monovalent cation composition and ATP and lipid content of irreversibly sickled cells. Blood 51: 1169-1178, 1978.
76. Corash L. Density dependent red cell separation. In: Red Cell Metabolism, edited by E. Beutler. New York: Churchill Livingstone, 1986, p. 90.
77. Dagher G and Lew VL. Maximal calcium extrusion capacity and stoichiometry of the human red cell calcium pump. J Physiol 407: 569-586, 1988.
78. De Franceschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Neuberg D, Beuzard Y, and Brugnara C. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. Br J Haematol 108: 284-289, 2000.
79. De Franceschi L, Beuzard Y, Jouault H, and Brugnara C. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse. Blood 88: 2738-2744, 1996.
80. De Franceschi L, Fumagalli L, Olivieri O, Corrocher R, Lowell CA, and Berton G. Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J Clin Invest 99: 220-227, 1997.
81. + transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest 93: 1670-1676, 1994.
82. Desai SA, Bezrukov SM, and Zimmerberg J. A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature 406: 1001-1005, 2000.
83. 2+ entry matches active extrusion in human erythrocytes. J Gen Physiol 98: 349-364, 1991.
84. Dover GJ, Boyer SH, Charache S, and Heintzelman K. Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med 299: 1428-1435, 1978.
85. Dunham PB and Hoffman JF. Partial purification of the ouabain-binding component and of Na,K-ATPase from human red cell membranes. Proc Natl Acad Sci USA 66: 936-943, 1970.
86. Dunham PB, Klimczak J, and Logue PJ. Swelling activation of K-Cl cotransport in LK sheep erythrocytes: a three-state process. J Gen Physiol 101: 733-765, 1993.
87. Dunham PB, Stewart GW, and Ellory JC. Chloride-activated passive potassium transport in human erythrocytes. Proc Natl Acad Sci USA 77: 1711-1715, 1980.
88. Dunn MJ. Red blood cell calcium and magnesium: effects upon sodium and potassium transport and cellular morphology. Biochim Biophys Acta 352: 97-116, 1974.
89. Eaton JW, Skelton TD, Swofford HS, Koplin CE, and Jacob HS. Elevated erythrocyte calcium in sickle cell disease. Nature 246: 105-106, 1973.
90. Eaton WA and Hofrichter J. Sickle cell hemoglobin polymerization. Ad Protein Chem 40: 63-279, 1990.
91. Egee S, Lapaix F, Decherf G, Staines HM, Ellory JC, Doerig C, and Thomas SL. A stretch-activated anion channel is up-regulated by the malaria parasite Plasmodium falciparum. J Physiol 542: 795-801, 2002.
92. + loss and dehydration (Abstract). J Physiol 467: 384P, 1993.
93. Engelmann B and Duhm J. Intracellular calcium content of human erythrocytes: relation to sodium transport systems. J Membr Biol 98: 79-87, 1987.
94. 86Rb) transport heterogeneity in the low-density fraction of sickle cell anemia red blood cells. Am J Physiol Cell Physiol 271: C1111-C1121, 1996.
95. Ca) (Abstract). Blood 80: 77a, 1992.
96. 2+ levels of sickle cell anemia red cells. J Clin Invest 92: 2489-2498, 1993.
97. Fabry ME and Nagel RL. Heterogeneity of red cells in the sickler: a characteristic with practical clinical and pathophysiological implications. Blood Cells 8: 9-15, 1982.
98. Fabry ME and Nagel RL. The effect of deoxygenation on red cell density: significance for the pathophysiology of sickle cell anemia. Blood 60: 1370-1377, 1982.
99. Fabry ME, Romero JR, Buchanan ID, Suzuka SM, Stamatoyannopoulos G, Nagel RL, and Canessa M. Rapid increase in red blood cell density driven by K:Cl cotransport in a subset of sickle cell anemia reticulocytes and discocytes. Blood 78: 217-225, 1991.
100. Ferreira HG and Lew VL. Use of ionophore A23187 to measure cytoplasmic Ca buffering and activation of the Ca pump by internal Ca. Nature 259: 47-49, 1976.
101. Flatman PW, Adragna NC, and Lauf PK. Role of protein kinases in regulating sheep erythrocyte K-Cl cotransport. Am J Physiol Cell Physiol 271: C255-C263, 1996.
102. Flatman PW and Lew VL. Use of ionophore A23187 to measure and to control free and bound cytoplasmic Mg in intact red cells. Nature 267: 360-362, 1977.
103. Flatman PW and Lew VL. Magnesium buffering in intact human red blood cells measured using the ionophore A23187. J Physiol 305: 13-30, 1980.
104. Flatman PW and Lew VL. The magnesium-dependence of sodium-pump-mediated sodium-potassium and sodium-sodium exchange in intact human red cells. J Physiol 315: 421-446, 1981.
105. Franco RS, Barker-Gear R, Miller MA, Williams SM, Joiner CH, and Rucknagel DL. Fetal hemoglobin and potassium in isolated transferrin receptor-positive dense sickle reticulocytes. Blood 84: 2013-2020, 1994.
106. Franco RS, Lohmann J, Silberstein EB, Mayfield-Pratt G, Palascak M, Nemeth TA, Joiner CH, Weiner M, and Rucknagel DL. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest 101: 2730-2740, 1998.
107. Franco RS, Palascak M, Thompson H, and Joiner CH. KCl cotransport activity in light versus dense transferrin receptor-positive sickle reticulocytes. J Clin Invest 95: 2573-2580, 1995.
108. Franco RS, Palascak M, Thompson H, Rucknagel DL, and Joiner CH. Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: role of KCl cotransport and extracellular calcium. Blood 88: 4359-4365, 1996.
109. Franco RS, Thompson H, Palascak M, and Joiner CH. The formation of transferrin receptor-positive sickle reticulocytes with intermediate density is not determined by fetal hemoglobin content. Blood 90: 3195-3203, 1997.
110. Freedman JC and Hoffman JF. Ionic and osmotic equilibria of human red blood cells treated with nystatin. J Gen Physiol 74: 157-185, 1979.
111. Freeman CJ, Bookchin RM, Ortiz OE, and Lew VL. K-permeabilized human red cells lose an alkaline, hypertonic fluid containing excess K over diffusible anions. J Membr Biol 96: 235-241, 1987.
112. Frohlich O. Relative contributions of the slippage and tunneling mechanisms to anion net efflux from human erythrocytes. J Gen Physiol 84: 877-803, 1984.
113. Frohlich O, Leibson C, and Gunn RB. Chloride net efflux from intact erythrocytes under slippage conditions. J Gen Physiol 81: 127-152, 1983.
114. Funder J and Wieth JO. Chloride and hydrogen ion distribution between human red cells and plasma. Acta Physiol Scand 68: 234-235, 1966.
115. García-Sancho J and Lew VL. Detection and separation of human red cells with different calcium contents following uniform calcium permeabilization. J Physiol 407: 505-522, 1988.
116. Gardos G. The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 30: 653-654, 1958.
117. Garrahan PJ and Glynn IM. The stoichiometry of the sodium pump. J Physiol 192: 217-235, 1967.
118. Gasbjerg PK, Funder J, and Brahm J. Kinetics of residual chloride transport in human red blood cells after maximum covalent 4,4′- diisothiocyanostilbene-2,2′-disulfonic acid binding. J Gen Physiol 101: 715-732, 1993.
119. + transport in sickle cells: the effect of different cell populations and the substituted benzaldehyde 12C79. FASEB J 15: 823-832, 2001.
120. - cotransporter in normal and sickle human red blood cells. J Physiol 511: 225-234, 1998.
121. Gillen CM, Brill S, Payne JA, and Forbush B III. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J Biol Chem 271: 16237-16244, 1996.
122. Glader BE, Lux SE, Muller-Soyano A, Platt OS, Propper RD, and Nathan DG. Energy reserve and cation composition of irreversibly sickled cells in vivo. Br J Haematol 40: 527-532, 1978.
123. Glader BE and Nathan DG. Cation permeability alterations during sickling: relation to cation composition and cellular hydration of irreversibly sickled cells. Blood 51: 983-989, 1978.
124. 2+-dependent thiol protease) in erythrocytes of young and old individuals. Proc Natl Acad Sci USA 91: 7879-7883, 1994.
125. Glynn IM and Karlish SJ. The sodium pump. Annu Rev Physiol 37: 13-55, 1975.
126. Groves JD and Tanner MJ. Glycophorin A facilitates the expression of human band 3-mediated anion transport in Xenopus oocytes. J Biol Chem 267: 22163-22170, 1992.
127. + currents in the membrane of human erythrocytes. Biochim Biophys Acta 902: 159-168, 1987.
128. + conductance of human red cells as revealed by the patch-clamp technique. Cell Calcium 4: 499-510, 1983.
129. + channels in human red cells. Comparison of single-channel currents with ion fluxes. Biophys J 45: 693-698, 1984.
130. Gunn RB, Dalmark M, Tosteson DC, and Wieth JO. Characteristics of chloride transport in human red blood cells. J Gen Physiol 61: 185-206, 1973.
131. Hall AC and Ellory JC. Effect of high hydrostatic pressure on "passive" monovalent cation transport in human red cells. J Membr Biol 94: 1-17, 1986.
132. Hall AC and Ellory JC. Evidence for the presence of volume-sensitive KCl transport in "young" human red cells. Biochim Biophys Acta 858: 317-320, 1986.
133. Harris JW. Studies on the destruction of red blood cells. VII. Molecular orientation in sickle cell hemoglobin solutions. Proc Soc Exp Biol Med 75: 197-201, 1950.
134. Harrison DG and Long C. The calcium content of human erythrocytes. J Physiol 199: 367-381, 1968.
135. Hebbel RP. Sickle hemoglobin instability: a mechanism for malarial protection. Redox Rep 8: 238-240, 2003.
136. Hladky SB and Rink TJ. pH equilibrium across the red cell membrane. In: Membrane Transport in Red Cells, edited by J. C. Ellory and V. L. Lew. London: Academic, 1977, p. 115-135.
137. + channel (Gardos channel) in human red blood cells. Proc Natl Acad Sci USA 100: 7366-7371, 2003.
138. Hoffman JF and Laris PC. Determination of membrane potentials in human and Amphiuma red blood cells by means of fluorescent probe. J Physiol 239: 519-552, 1974.
139. Hoffman JF and Laris PC. Membrane electrical parameters of normal human red blood cells. Soc Gen Physiol Ser 38: 287-293, 1984.
140. Hoffmann EK and Simonsen LO. Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol Rev 69: 315-382, 1989.
141. Holroyde CP and Gardner FH. Acquisition of autophagic vacuoles by human erythrocytes. Physiological role of the spleen. Blood 36: 566-575, 1970.
142. Holtzclaw JD, Jiang M, Yasin Z, Joiner CH, and Franco RS. Rehydration of high-density sickle erythrocytes in vitro. Blood 100: 3017-3025, 2002.
143. Hunter MJ. A quantitative estimate of the non-exchange-restricted chloride permeability of the human red cell (Abstract). J Physiol 218: 49P-50P, 1971.
144. Hunter MJ. Human erythrocyte anion permeabilities measured under conditions of net charge transfer. J Physiol 268: 35-49, 1977.
145. Ingram VM. A specific chemical difference between the globins of normal human and sickle-cell anemia hemoglobin. Nature 178: 792-794, 1956.
146. Ingram VM. Gene mutations in human hemoglobin: the chemical difference between normal and sickle cell hemoglobin. Nature 180: 326-328, 1957.
147. Jacobs MH and Stewart DR. The role of carbonic anhydrase in certain ionic exchanges involving the erythrocyte. J Gen Physiol 25: 539-552, 1942.
148. Jacobs MH and Stewart DR. Osmotic properties of the erythrocyte. XII. Ionic and osmotic equilibria with a complex external solution. J Cell Comp Physiol 30: 79-103, 1947.
149. 2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem 264: 8289-8296, 1989.
150. Jennings ML. Volume-sensitive K(+)/Cl(-) cotransport in rabbit erythrocytes. Analysis of the rate-limiting activation and inactivation events. J Gen Physiol 114: 743-758, 1999.
151. Jennings ML and Adame MF. Direct estimate of 1:1 stoichiometry of K(+)-Cl(-) cotransport in rabbit erythrocytes. Am J Physiol Cell Physiol 281: C825-C832, 2001.
152. - transport. The volume-sensitive parameter is the rate constant for inactivation. J Gen Physiol 95: 1021-1040, 1990.
153. Jennings ML and Schulz RK. Okadaic acid inhibition of KCl cotransport. Evidence that protein dephosphorylation is necessary for activation of transport by either cell swelling or N-ethylmaleimide. J Gen Physiol 97: 799-817, 1991.
154. v-src. Proc Natl Acad Sci USA 83: 207-211, 1986.
155. Johnstone RM. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol 70: 179-190, 1992.
156. Johnstone RM, Adam M, Hammond JR, Orr L, and Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262: 9412-9420, 1987.
157. Johnstone RM and Ahn J. A common mechanism may be involved in the selective loss of plasma membrane functions during reticulocyte maturation. Biomed Biochim Acta 49: S70-S75, 1990.
158. Johnstone RM, Bianchini A, and Teng K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood 74: 1844-1851, 1989.
159. Johnstone RM, Mathew A, Mason AB, and Teng K. Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol 147: 27-36, 1991.
160. Joiner CH. Studies on the mechanism of passive cation fluxes activated by deoxygenation of sickle cells. Prog Clin Biol Res 240: 229-235, 1987.
161. Joiner CH. Deoxygenation-induced cation fluxes in sickle cells. II. Inhibition by stilbene disulfonates. Blood 76: 212-220, 1990.
162. Joiner CH. Cation transport and volume regulation in sickle red blood cells. Am J Physiol Cell Physiol 264: C251-C270, 1993.
163. Joiner CH and Franco RS. The activation of KCl cotransport by deoxygenation and its role in sickle cell dehydration. Blood Cells Mol Dis 27: 158-164, 2001.
164. Joiner CH, Gunn RB, and Frohlich O. Anion transport in sickle red blood cells. Pediatr Res 28: 587-590, 1990.
165. Joiner CH, Jiang M, Claussen WJ, Roszell NJ, Yasin Z, and Franco RS. Dipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells. Blood 97: 3976-3983, 2001.
166. + exchange. Am J Physiol Cell Physiol 274: C1466-C1475, 1998.
167. Joiner CH, Jiang M, and Franco RS. Deoxygenation-induced cation fluxes in sickle cells. IV. Modulation by external calcium. Am J Physiol Cell Physiol 269: C403-C409, 1995.
168. Joiner CH and Lauf PK. The correlation between ouabain binding and potassium pump inhibition in human and sheep erythrocytes. J Physiol 283: 155-175, 1978.
169. Joiner CH, Morris CL, and Cooper ES. Deoxygenation-induced cation fluxes in sickle cells. III. Cation selectivity and response to pH and membrane potential. Am J Physiol Cell Physiol 264: C734-C744, 1993.
170. Joiner CH, Platt OS, and Lux SE. Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes. J Clin Invest 78: 1487-1496, 1986.
171. Joiner CH, Rettig RK, Jiang M, and Franco RS. KCl cotransport mediates abnormal, sulfhydryl-dependent volume regulation in sickle reticulocytes. Blood. In press.
172. Kaul DK and Fabry ME. In vivo studies of sickle red blood cells. Microcirculation 11: 1-13, 2004.
173. Knauf PA, Fuhrmann GF, Rothstein S, and Rothstein A. The relationship between anion exchange and net anion flow across the human red blood cell membrane. J Gen Physiol 69: 363-386, 1977.
174. Knauf PA, Law FY, and Marchant PJ. Relationship of net chloride flow across the human erythrocyte membrane to the anion exchange mechanism. J Gen Physiol 81: 95-126, 1983.
175. Kopito RR. Molecular biology of the anion exchanger gene family. Int Rev Cytol 123: 177-199, 1990.
176. Laris PC and Hoffman JF. Optical determination of electrical properties of red blood cell and Ehrlich ascites tumor cell membranes with fluorescent dyes. Soc Gen Physiol Ser 40: 199-210, 1986.
177. Lassen UV. Electrical potential and conductance of the red cell membrane. In: Membrane Transport in Red Cells, edited by J. C. Ellory and V. L. Lew. London: Academic, 1977, p. 137-172
178. - cotransport: sulfhydryls, divalent
179. + sheep erythrocytes: modulation by A23187 and bivalent cations. Am J Physiol Cell Physiol 249: C271-C278, 1985.
180. Lauf PK and Adragna PK NC. K-Cl cotransport: properties and molecular mechanism. Cell Physiol Biochem 10: 341-354, 2000.
181. Lauf PK, Bauer J, Adragna NC, Fujise H, Zade-Oppen AMM, Ryu KH, and Delpire E. Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol Cell Physiol 263: C917-C932, 1992.
182. Lauf PK, McManus TJ, Haas M, Forbush B, Duhm J III, Flatman PW, Saier MH Jr, and Russell JM. Physiology and biophysics of chloride and cation cotransport across cell membranes. Federation Proc 46: 2377-2394, 1987.
183. - flux in human red blood cells. Am J Physiol Cell Physiol 249: C124-C128, 1985.
184. + sheep and goat erythrocytes. Biochem Biophys Res Commun 92: 1422-1428, 1980.
185. Lehmann H. Treatment of sickle-cell anemia. Br Med J 5338: 1158-1159, 1963.
186. Lew VL and Beaugé LA. Passive cation fluxes in red cell membranes. In: Transport Across Biological Membranes, edited by G. Giebisch, D. C. Tosteson, and H. H. Ussing. Berlin: Springer-Verlag, 1979, vol. 11, p. 85-115.
187. 2+-refractory state of the Ca-sensitive K permeability mechanism in sickle cell anemia red cells. Biochim Biophys Acta 602: 196-200, 1980.
188. Lew VL and Bookchin RM. Volume, pH and-ion content regulation in human red cells: analysis of transient behavior with an integrated model. J Membr Biol 92: 57-74, 1986.
189. Lew VL and Bookchin RM. The osmotic effects of protein polymerization. Analysis of volume changes in sickle cell anemia red cells following deoxy-hemoglobin S polymerization. J Membr Biol 122: 55-67, 1991.
190. Lew VL and Bookchin RM. Role of reticulocyte transport heterogeneity in the generation of mature sickle cells with different volumes. Biochem Soc Trans 20: 797-800, 1992.
191. Lew VL and Bookchin RM. Osmotic effects of water compartments in protein polymers. Cell Biochem Funct 13: 173-176, 1995.
192. 2+ pump activity in normal human red blood cells. Blood 102: 4206-4213, 2003.
193. Lew VL, Etzion Z, and Bookchin RM. Dehydration response of sickle cells to sickling-induced Ca(+ +) permeabilization. Blood 99: 2578-2585, 2002.
194. Lew VL and Ferreira HG. Variable Ca sensitivity of a K-selective channel in intact red-cell membranes. Nature 263: 336-338, 1976.
195. Lew VL and Ferreira HG. Calcium transport and the properties of a calcium-activated potassium channel in red cell membranes. In: Current Topics in Membranes and Transport, edited by A. Kleinzeller and F. Bronner. New York: Academic, 1978, vol. 10, p. 217-277.
196. Lew VL, Ferreira HG, and Moura T. The behaviour of transporting epithelial cells. I. Computer analysis of a basic model. Proc R Soc Lond B Biol Sci 206: 53-83, 1979.
197. Lew VL, Freeman CJ, Ortiz OE, and Bookchin RM. A mathematical model on the volume, pH and ion content regulation of reticulocytes. Application to the pathophysiology of sickle cell dehydration. J Clin Invest 87: 100-112, 1991.
198. Lew VL and García-Sancho J. Measurement and control of intracellular calcium in intact red cells. In: Methods in Enzymology. Biomembranes. Cellular and Subcellular Transport: Eukaryotic (Nonepithelial) Cells, edited by S. Fleischer and B. Fleischer. San Diego, CA: Academic, 1989, vol. 173, pt. T, p. 100-112.
199. Lew VL, Hockaday A, Sepulveda MI, Somlyo AP, Somlyo AV, Ortiz OE, and Bookchin RM. Compartmentalization of sickle cell calcium in endocytic inside-out vesicles. Nature 315: 586-589, 1985.
200. + channel in one-step inside-out vesicles from human red cell membranes. Nature 296: 742-744, 1982.
201. 2+ permeability. J Clin Invest 99: 2727-2735, 1997.
202. Lew VL, Raftos JE, Sorette MP, Bookchin RM, and Mohandas N. Generation of normal human red cell volume, hemoglobin content and membrane area distributions, by "birth" or regulation? Blood 86: 334-341, 1995.
203. Lew VL and Simonsen LO. Ionophore A23187-induced calcium permeability of intact human red blood cells (Abstract). J Physiol 308: 60P, 1980.
204. 45Ca-flux kinetics reveals uniform ionophore distribution and cytoplasmic calcium buffering in ATP-depleted human red cells. J Physiol 316: 6P-7P, 1981.
205. Lew VL, Tiffert T, Etzion Z, Perdomo D, Daw N, MacDonald L, and Bookchin RM. Distribution of dehydration rates generated by maximal Gardos channel activation in normal and sickle red blood cells. Blood. In press.
206. 2+], level and pump-leak turnover in intact red cells measured using an incorporated Ca chelator. Nature 298: 478-481, 1982.
207. 2+-mediated crosslinking of erythrocyte proteins. Biochemistry 75: 4479-4481, 1976.
208. Lutz HU. Erythrocyte clearance. In: Blood Cell Chemistry. Erythroid Cells, edited by J. R. Harris. New York: Plenum, 1990, vol. 1, p. 81-120.
209. Lux SE. Spectrin-actin membrane skeleton of normal and abnormal red blood cells. Semin Hematol 16: 21-51, 1979.
210. Lux SE, John KM, and Karnovsky MJ. Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells. J Clin Invest 58: 955-963, 1976.
211. Mairbaurl H, Schulz S, and Hoffman JF. Cation transport and cell volume changes in maturing rat reticulocytes. Am J Physiol Cell Physiol 279: C1621-C1630, 2000.
212. McGoron AJ, Joiner CH, Palascak MB, Claussen WJ, and Franco RS. Dehydration of mature and immature sickle red blood cells during fast oxygenation/deoxygenation cycles: role of KCl cotransport and extracellular calcium. Blood 95: 2164-2168, 2000.
213. Merciris P, Claussen WJ, Joiner CH, and Giraud F. Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells. Pflügers Arch 446: 232-238, 2003.
214. Ohnishi ST. Inhibition of the in vitro formation of irreversibly sickled cells by cepharanthine. Br J Haematol 55: 665-671, 1983.
215. Orringer EP, Blythe DS, Johnson AE, Phillips G Jr, Dover GJ, and Parker JC. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 78: 212-216, 1991.
216. 86Rb) flux components. Blood 67: 710-715, 1986.
217. Ortiz OE, Lew VL, and Bookchin RM. Deoxygenation permeabilizes sickle cell anemia red cells to magnesium and reverses its gradient in the dense cells. J Physiol 427: 211-226, 1990.
218. Palek J. Calcium accumulation during sickling of hemoglobin S red cells. Blood 42: 988-1000, 1973.
219. Palek J and Lambert S. Genetics of the red cell membrane skeleton. Semin Hematol 27: 290-332, 1990.
220. Palek J and Liu SC. Membrane protein organization in ATP-depleted and irreversibly sickled cells. J Supramol Struct 10: 79-96, 1979.
221. Pauling L, Itano H, Singer SJ, and Wells IC. Sickle cell anemia: a molecular disease. Science 110: 543-548, 1949.
222. Pearson HA, Cornelius EA, Schwartz AD, Zelson JH, Wolfson SL, and Spencer RP. Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 283: 334-337, 1970.
223. Pearson HA, Spencer RP, and Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 281: 923-926, 1969.
224. Perutz MF and Mitchison JM. State of hemoglobin in sickle-cell anemia. Nature 166: 677-679, 1950.
225. Petersen OH and Maruyama Y. Calcium-activated potassium channels and their role in secretion. Nature 307: 693-696, 1984.
226. Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, and Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 74: 652-656, 1984.
227. Post RL. A reminiscence about sodium, potassium-ATPase. Ann NY Acad Sci 242: 6-11, 1974.
228. Post RL, Albright CD, and Dayani K. Resolution of pump and leak components of sodium and potassium ion transport in human erythrocytes. J Gen Physiol 50: 1201-1220, 1967.
229. Pressman BC. Biological applications of ionophores. Annu Rev Biochem 45: 501-530, 1976.
230. Raftos JE and Lew VL. Effect of intracellular magnesium on calcium extrusion by the plasma membrane calcium pump of intact human red cells. J Physiol 489: 63-72, 1995.
231. Rapoport S, Guest GM, and Wing M. Size, hemoglobin content, and acid-soluble phosphorus of erythrocytes of rabbits with phenylhydrazine-induced reticulocytosis. Proc Soc Exp Biol Med 57: 334, 1944.
232. Rapoport SM. The Reticulocyte. Boca Raton, FL: CRC, 1986.
233. Reed PW and Lardy HA. A23187: a divalent cation ionophore. J Biol Chem 247: 6970-6977, 1972.
234. 2+ Pump of Plasma Membranes. Boca Raton, FL: CRC, 1986.
235. Rifai N, Sakamoto M, Law T, Platt O, Mikati M, Armsby CC, and Brugnara C. HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agent. Clin Chem 41: 387-391, 1995.
236. 2+ levels. J Cell Physiol 126: 53-59, 1986.
237. Sarkadi B, Szasz I, and Gardos G. The use of ionophores for rapid loading of human red cells with radioactive cations for cation pump studies. J Membr Biol 26: 357-370, 1976.
238. 2+-extrusion from human red cells. Experientia 22: 364-365, 1966.
239. Schatzmann HJ and Vincenzi FF. Calcium movements across the membrane of human red cells. J Physiol 201: 369-395, 1969.
240. Serjeant GR. The emerging understanding of sickle cell disease. Br J Haematol 112: 3-18, 2001.
241. Serjeant GR, Serjeant BE, and Milner PF. The irreversibly sickled cell: a determinant of haemolysis in sickle cell anemia. Br J Haematol 17: 527-533, 1969.
242. Simons TJB. Calcium-dependent potassium exchange in human red cell ghosts. J Physiol 256: 227-244, 1976.
243. Simonsen LO. Binding of ionophore A23187 by bovine plasma albumin. J Physiol 313: 34, 1981.
244. Simonsen LO, Gomme J, and Lew VL. Uniform ionophore A23187 distribution and cytoplasmic calcium buffering in intact human red cells. Biochim Biophys Acta 692: 431-440, 1982.
245. Simonsen LO and Lew VL. The correlation between ionophore A23187 content and calcium permeability of ATP-depleted human red blood cells. In: Membrane Transport in Erythrocytes, edited by U. V. Lassen, H. H. Ussing, and J. O. Wieth. Copenhagen: Munksgaard, 1980, p. 208-212.
246. Singer K and Singer L. Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance. Blood 8: 1008-1023, 1953.
247. Skou JC and Esmann M. The Na,K-ATPase. J Bioenerg Biomembr 24: 249-261, 1992.
248. Speake PF and Gibson JS. Urea-stimulated K-Cl cotransport in equine red blood cells. Pflügers Arch 434: 104-112, 1997.
249. Starke LC and Jennings ML. K-Cl cotransport in rabbit red cells: further evidence for regulation by protein phosphatase type 1. Am J Physiol Cell Physiol 264: C118-C124, 1993.
250. Steck TL. The organization of proteins in the human red blood cell membrane. J Cell Biol 62: 1-19, 1974.
251. Steinberg MH. Therapies to increase fetal hemoglobin in sickle cell disease. Curr Hematol Rep 2: 95-101, 2003.
252. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, and Terrin M. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289: 1645-1651, 2003.
253. Steinberg MH and Brugnara C. Pathophysiological-based approaches to treatment of sickle cell disease. Annu Rev Med 54: 89-112, 2003.
254. Stocker JW, De Franceschi L, McNaughton-Smith GA, Corrocher R, Beuzard Y, and Brugnara C. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 101: 2412-2418, 2003.
255. Sunshine HR, Hofrichter J, and Eaton WA. Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins. J Mol Biol 133: 435-467, 1979.
256. Tanner MJ. The major integral proteins of the human red cell. Baillieres Clin Haematol 6: 333-356, 1993.
257. 2+ spiking. J Biol Chem 267: 14073-14076, 1992.
258. Tiffert T, Bookchin RM, and Lew VL. Calcium homeostasis in normal and abnormal human red cells. In: Red Cell Membrane Transport in Health and Disease, edited by I. Bernhardt and J. C. Ellory. Berlin: Springer-Verlag, 2003, p. 373-405.
259. Tiffert T, Daw N, Perdomo D, and Lew VL. A fast and simple screening test to search for specific inhibitors of the plasma membrane calcium pump. J Lab Clin Med 137: 199-207, 2001.
260. 2+ buffering in normal human red cells. J Physiol 464: 529-544, 1993.
261. Tiffert T, García-Sancho J, and Lew VL. Irreversible ATP depletion caused by low concentrations of formaldehyde and of calcium-chelator esters in intact human red cells. Biochim Biophys Acta 773: 143-156, 1984.
262. 2+ buffers in intact human red cells. J Physiol 500: 139-154, 1997.
263. Tiffert T and Lew VL. Kinetics of inhibition of the plasma membrane calcium pump by vanadate in intact human red cells. Cell Calcium 30: 337-342, 2001.
264. Tiffert T, Spivak JL, and Lew VL. Magnitude of calcium influx required to induce dehydration of normal human red cells. Biochim Biophys Acta 943: 157-165, 1988.
265. Tosteson DC. The effects of sickling on ion transport. II. The effect of sickling on sodium and cesium transport. J Gen Physiol 39: 55-67, 1955.
266. Tosteson DC, Carlsen E, and Dunham ET. The effects of sickling on ion transport. I. Effect of sickling on potassium transport. J Gen Physiol 39: 31-53, 1955.
267. Tosteson DC and Hoffman JF. Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J Gen Physiol 44: 169-194, 1960.
268. Tosteson DC, Shea E, and Darling RC. Potassium and sodium of red blood cells in sickle cell anemia. J Clin Invest 31: 406-411, 1952.
269. + channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem 273: 21542-21553, 1998.
270. 2+ pump. J Membr Biol 112: 233-245, 1989.
271. Wang KKW, Villalobo A, and Roufogalis BD. The plasma membrane calcium pump: a multiregulated transporter. Trends Cell Biol 2: 46-52, 1992.
272. Watson J, Stahman AW, and Bilello FP. The significance of the paucity of sickle cells in newborn Negro infants. Am J Med Sci 215: 419-423, 1948.
273. Whittam R. Transport and Diffusion in Red Blood Cells. London: Arnold, 1964.
274. Wiley JS. Increased erythrocyte cation permeability in thalassemia and conditions of marrow stress. J Clin Invest 67: 917-922, 1981.
275. 2+ accumulation and loss by aberrant endocytic vesicles in sickle erythrocytes. J Cell Physiol 152: 1-9, 1992.
276. + channel of Hb A and Hb S red cells: individual differences in the number of channels. J Membr Biol 106: 243-252, 1988.
277. 2+ ATPase (SERCA). J Biol Chem 279: 17973-17979, 2004.